The decreased expression of TET2 in PBMCs might be related to lower demethylation because less 5-mC is converted to 5-hmC, resulting in a different pattern of global methylation and hydroxymethylation, which in turn might promote the inflammatory state in MS. Here, TET2 is linked to myeloid sarcoma.